Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zabofloxacin vs Moxifloxacin in Acute Bacterial Exacerbation of COPD
NCT01658020Phase 3Completed
- Sponsor
- Dongwha Pharmaceutical Co., Ltd.
- Start
- Aug 2012
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zabofloxacin in chronic obstructive pulmonary disease (COPD), sponsored by Dongwha Pharmaceutical Co., Ltd.. Started Aug 2012; status: completed.
02
Drugs
zabofloxacin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01658020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01658020.